Skip to content

Explore the publication

Healthcare & Power

All stories

Healthcare & Power

NUCLIDIUM Secures NorthStar Copper-67 Supply and Manufacturing Ahead of Planned Therapy Studies

NUCLIDIUM and NorthStar say NorthStar will produce copper-67 and manufacture radiopharmaceuticals for NUCLIDIUM’s programs. No terms, volumes or capacity figures were disclosed, and the therapies remain investigational with no efficacy results reported.

Read the story